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Abstract
Transgenic animals have been used for years to study gene function, produce important proteins, and generate models for
the study of human diseases. However, inheritance and expression instability of the transgene in transgenic animals is a
major limitation. Copy number and promoter methylation are known to regulate gene expression, but no report has
systematically examined their effect on transgene expression. In the study, we generated two transgenic pigs by somatic
cell nuclear transfer (SCNT) that express green fluorescent protein (GFP) driven by cytomegalovirus (CMV). Absolute
quantitative real-time PCR and bisulfite sequencing were performed to determine transgene copy number and promoter
methylation level. The correlation of transgene expression with copy number and promoter methylation was analyzed in
individual development, fibroblast cells, various tissues, and offspring of the transgenic pigs. Our results demonstrate that
transgene expression is associated with copy number and CMV promoter methylation in transgenic pigs.
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Introduction
Transgenic animals are a powerful tool in the fields of
experimental and applied biology. These animals allow study into
the function and regulation of genes in vivo, the production of
important pharmaceutical proteins, and the creation of pathologic
models for human disease therapy [1]. Recent progress in animal
cloning has provided an attractive alternative to improve
transgenic efficiency, through the combination of transfection
and somatic cell nuclear transfer (SCNT).
To date, the cloning of pigs has been used successfully to
produce transgenic animals expressing enhance green fluorescence
protein (eGFP) [2] and omega-3 fatty acids [3], and an a-1,3-
galactosyltransferase deficient pig, which has the potential to be
used as an organ donor for xenotransplantation [4]. The
production of genetically modified pigs by nuclear transfer has
progressed from basic research to practical use. Despite this
impressive and growing success, transgenesis still suffers from
many limitations. Numerous experiments have shown that the
inheritance and expression of the transgene in transgenic animals
is predictable only to a limited extent [5–8]. In most cases,
transgene expression levels in transfected cells often decline with
time [6]. Furthermore, the level of transgene expression appears to
correlate inversely with time [9], and the majority of transgenic
animals cannot stably pass the transgene to their offspring.
Therefore, it is difficult to select founder transgenic animals to
establish a line of transgenic animals [7]. Recently, several reports
have demonstrated that induced pluripotent stem cells (iPS) may
possess mechanisms to lower the expression level of the four factors
(Oct3/4, Sox2, c-Myc, and Klf4) and make them expression
silencing after full-reprogramming [10–12].
Mechanisms causing this phenomenon of transgene instability
are poorly understood. Generally, transgene copy number and
DNA methylation status can influence transgene expression [13].
These are often considered as main factors resulting in incomplete
and complete silencing of transgene expression [14]. In most cases,
multiple copies of the transgene, arrayed in a head-to-tail manner,
are randomly integrated in the host genome, which may cause
transcriptional interference that represses expression [15–17]. As
long as the transgene is expressed appropriately, calculating the
copy number is not usually performed. DNA methylation is the
strongest candidate for expression silencing, because it can lead to
transcriptional inactivity of certain genes, may be stably inherited
through mitosis, and may be transmitted to subsequent genera-
tions [18–20]. In particular, promoter methylation has been
associated with transgene silencing in vitro and in vivo [21–23].
A more clear understanding of the factors influencing transgene
expression would improve the production of transgenic animals. In
order to test the relationship between transgene expression and
copy number or promoter methylation, we generated two GFP
transgenic pigs by SCNT and analyzed GFP expression, copy
number and CMV methylation in regards to individual develop-
ment, fibroblast cells, various tissues, and the offspring of the
transgenic pigs. Our results suggest that transgene expression is
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6679regulated by methylation of the promoter and by transgene copy
number.
Results
Generation of transgenic pig
A total of 1978 reconstructed embryos were transferred to ten
recipients. Three recipients became pregnant and four founder
GFP-positive transgenic pigs were born at full term. Finally, two
female pigs, named K25-2 and K25-3, survived to maturity (the
others died at birth). After mating with non-transgenic pigs, K25-2
produced seven F1 positive pigs from two litters, but K25-3 died
during delivery. Variable factors may decrease the success rate of
producing transgenic animals, and an additional difficulty in pigs
requires that at least four good embryos are needed to induce and
maintain pregnancy [3]. In the present study, the overall efficiency
of transgenic pig production was 0.69%.
Expression of GFP
We analyzed the change in GFP expression in relation to aging
in ear tissues of transgenic pigs. A significant decline in the mRNA
level was observed from newborn to maturity in both K25-2 and
K25-3 (p,0.001). The mRNA level decreased about 1-fold and 3-
fold in K25-2 and K25-3, respectively (Fig. 1A). These results were
consistent with results from Western blot analysis (Fig. 1B). These
data indicate that the transgene expression level decreases with
aging in vivo.
In order to examine whether the expression of the transgene
also declined in vitro, fibroblast cells from K25-3 were cultured in
vitro up to 90 days were analyzed for transgene expression. A
Figure 1. Expression of GFP. (A) Relative real-time RT-PCR analysis of GFP mRNA expression from newborn to maturity in founder transgenic pigs.
The decline was significant in both K25-2 and K25-3 (p,0.001); (B) Western blots analysis of GFP protein from newborn to maturity in founder
transgenic pigs; (C) Relative real-time RT-PCR analysis of GFP mRNA expression in transgenic fibroblast cells. The decline of mRNA from 20 to 90 days
was significant (p,0.001); (D) Flow cytometry analysis of the percentage of phenotype positive cells. The decline of percentage of positive cells from
20 to 90 days was also significant (p,0.001); (E) Relative real-time RT-PCR analysis of GFP mRNA expression in various tissues of the transgenic pig.
Variegation of GFP mRNA expression was shown in different tissues (p,0.001); (F) Western blots analysis of GFP protein in various tissues; (G) Relative
real-time RT-PCR analysis of GFP mRNA expression in offspring transgenic pigs. The decline from founder to offspring was significant (p,0.001); (H)
Western blots analysis of GFP protein in offspring transgenic pigs. Error bars denote standard deviations. Neg., non-transgenic pig.
doi:10.1371/journal.pone.0006679.g001
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observed from 20 to 90 days in culture (p,0.001) (Fig. 1C). Flow
cytometry analysis also showed a significant decline (almost 8-fold)
in the percentage of cells that expressed GFP (p,0.001) (Fig. 1D).
A decrease in fluorescence intensity from 20 to 90 days was also
found by flow cytometry analysis (data not shown). Previous
reports have demonstrated that transgene silencing in transgenic
cells may occur through a decline in expression levels rather than
in the proportion of expressing cells [6,17,24], but the present data
do not clarify this point, and a decrease in the percentage of
positive cells was evident.
GFP expression was detected in different tissues of K25-3,
namely intestine, ovary, uterus, lung, liver, tongue, kidney, heart,
muscle, spleen, adipose and stomach. However, significant
difference was found in the mRNA levels observed in these tissues
(p,0.001). In tongue, heart, muscle and stomach, mRNA levels
were almost 20-fold higher compared to that in spleen, adipose,
ovary and uterus (Fig. 1E). The difference was confirmed by
Western blot analysis (Fig. 1F). To examine the GFP expression
pattern directly, different tissues were observed under UV light
(Fig. 2), and a variegation of expression was observed. These
results are consistent with previous studies in that transgene
expression in transgenic animals may be different between tissues
[25,26].
GFP expression was detected in offspring of K25-2, and was
varied. The mRNA expression in offspring was significantly lower
(more than 5-fold) compared to that in the founder (p,0.001)
(Fig. 1G). Western blot analysis also showed a decline between
K25-2 and its offspring (Fig. 1H). These findings suggest that the
expression of the transgene in transgenic animals does not stably
pass to their offspring.
Copy number of GFP
In order to determine the correlation of transgene expression
with copy number, we examined the GFP copy number in ears of
newborn and mature transgenic pigs. A decline in copy number
was found by absolute quantitative real-time PCR (Fig. 3A) and
Southern blot analysis (Fig. 3B). Although a significant decline was
not detected in K25-2 (p=0.099), the decline in K25-3 was
significant (p=0.016). A more than 4-copy drop was observed in
K25-2, and a more than 6-copy drop was observed in K25-3
(table 1). Transgenic animals show a difference in transgene copy
number [27,28], but a decline in the copy number with aging is
not a common observation.
We also analyzed the GFP copy number in transgenic fibroblast
cells cultured in vitro for up to 90 days. The data showed that the
GFP copy number declined significantly (p,0.001) and the copy
number decreased almost 6-fold from 20 to 90 days (Fig. 3C).
These results are consistent with the conclusion that transgene
copies may be lost in transgenic cells over time in vitro [6]. In
addition, we observed a significant correlation between GFP
expression levels and copy number in transgenic fibroblast cells
(r=0.965, p,0.001). These results suggest that the decline of
transgene expression may be due to the loss of copies.
The GFP copy number in various tissues of K25-3 was also
tested (Fig. 3D). Although the copy number in different tissues was
varied, the difference was not significant (p=0.059) and not clearly
shown by Southern blots (data not shown). In muscle, heart and
lung, the GFP copy number was about 3 copies more than that in
adipose, ovary and spleen. In addition, the correlation between
GFP expression and copy number in different tissues was
significant (r=0.851, p,0.001). In our earlier report, we
demonstrated a mosaic genotype in a transgenic pig that died at
birth. In that animal, we did not observe GFP sequence in muscle
by PCR analysis [29], but, in the present study, this phenomenon
was not observed.
Transgene loss during passage is common [27,30]. In present
study, the loss of GFP copies during passage of K25-2 was
significant (p,0.001), and the GFP copy number in different
offspring varied (Fig. 3E). Moreover, the observed loss of GFP
copies was 15 copies at most and 9 copies at least (Table 2).
Southern blots confirmed the decline (Fig. 3F). The correlation of
GFP expression level with copy number was significant in this case
(r=0.864, p=0.006). These results suggest that transgenic animals
may transmit the transgene to their offspring only to a limited
extent, and this loss of transgene copies is responsible for the
expression decline.
Methylation status of CMV promoter
Transgene expression may be regulated by copy number and
repressed by DNA methylation. Therefore, we examined the
methylation status of a 278-bp region of the CMV promoter
containing one CpG island with 14 CpG sites. The bisulfite
sequencing method is able to reveal the methylation status of all
the cytosine residues in a DNA region of interest [31].
The bisulfite sequence data for a representative region of CMV
promoter is shown in Fig. 4). On average, 99% of the cytosine
residues in the pEGFP-C1 plasmid were converted to thymidine,
indicating that the bisulfite conversion reaction on other samples
was at least 99% efficient. The converted or unconverted cytosines
at CpG sites (on a red background) indicate unmethylated or
methylated. Interestingly, there were some unconverted cytosines
at non-CpG sites (on a pink background), indicating cytosines that
might be methylated. Extensive non-CpG methylation of the
CMV promoter has been reported and associated with transgene
silencing [22]. However, in this study, these cytosines were not
included methylation level analysis because we did not know the
mechanism of non-CpG methylation.
We detected CMV methylation levels in ears of newborn and
mature transgenic pigs, and observed an increase from 26% to
40% (p=1.000) and from 19% to 38% (p=0.799) in K25-2 and
K25-3, respectively (Fig. 5A).
In the analysis of CMV methylation in transgenic fibroblast cells
cultured from 20 to 90 days (Fig. 5B), we found that the level
increased more than 3-fold from 26% to 81% (p=0.053), and the
increase in CMV methylation was conversely correlated with GFP
expression (r=20.967, p,0.001). These results suggest that the
methylation level of the transgene promoter appears to increase in
vivo or in vitro, and to repress transgene expression.
A variegation of CMV methylation in different tissues of K25-3
was detected (Fig. 5C). There was a hypermethylation level in
uterus (67%), spleen (67%) and adipose (71%), and a hypomethy-
lation level in heart (38%) and muscle (30%). However, the
difference in the methylation levels in different tissues was not
significant (p=0.153). The correlation of GFP expression with
CMV methylation in different tissues was significant (r=20.982,
p,0.001), indicating that transgene expression is associated with
promoter methylation in transgenic animal tissues, which is
consistent with a recent report [23].
A change in CMV methylation during passage was also
observed between K25-2 and its offspring (Fig. 5D). The increase
in CMV methylation levels between founder and offspring, from
40% to 58% on average of offspring, was not significant
(p=0.537), and there was no significant correlation of GFP
expression with CMV methylation (r=20.682, p=0.063).
Though a wide range of methylation levels from 50% to 74%
among offspring was observed, the difference was not significant
(p=0.615). The complex inheritance of transgene promoter
Transgene Expression in Pig
PLoS ONE | www.plosone.org 3 August 2009 | Volume 4 | Issue 8 | e6679Figure 2. Variegation of GFP expression in various tissues of the transgenic pig. A to L: different tissues, namely uterus, spleen, ovary,
muscle, liver, intestine, lung, tongue, kidney, stomach, heart and adipose, were visualized by HE staining. A1 to L1: tissues under normal light. A2 to
L2: tissues under UV light.
doi:10.1371/journal.pone.0006679.g002
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reset.
In these cases, we did not find significant differences in the
methylation level, and the results observed may be related to
cellular mosaicism and environment influences on methylation
status [20,32].
Effect of copy number and promoter methylation on
transgene expression
In order to determine which factor, copy number or promoter
methylation, is more significant in the determination of transgene
Figure 3. Copy number of GFP. (A) Absolute quantitative real-time PCR analysis of GFP copy number from newborn to maturity in founder
transgenic pigs. There was no statistically significant decline in K25-2 (p=0.099), but the decline in K25-3 was significant (p=0.016); (B) Southern
blots analysis of GFP copy number in newborn and mature transgenic pigs; (C) Absolute quantitative real-time PCR analysis of GFP copy number in
transgenic fibroblast cells. Copy number of GFP declined in cells over time in culture. The decline was significant (p,0.001); (D) Variegation of GFP
copy number in various tissues of transgenic pig. Variegation of GFP copies was shown in different tissues (p=0.059); (E) Absolute quantitative real-
time PCR analysis of GFP copy number in offspring transgenic pigs. The decline from founder to offspring was significant (p,0.001); (F) Southern
blots analysis of GFP copy number in offspring transgenic pigs. Error bars denote standard deviations. Neg., non-transgenic pig.
doi:10.1371/journal.pone.0006679.g003
Table 1. GFP copies in newborn and mature founder
transgenic pigs.
Pig Term No. of Copies
K25-2 Newborn 23.62
a62.59
Mature 18.87
a61.34
K25-3 Newborn 37.59
b61.79
Mature 30.85
c61.77
Note: Different superscripts indicate statistical difference (P,0.05).
doi:10.1371/journal.pone.0006679.t001
Table 2. Copy number of GFP in K25-2 and its offspring.
Generations Litters Pigs No. of Copies
F0 — K25-2 18.87
a61.34
F1 First 1 7.01
cd60.34
2 6.86
cd60.52
3 9.89
b61.09
4 9.19
bc61.20
Second 1 3.67
e60.59
2 5.71
de60.85
3 9.54
bc60.84
Note: Different superscripts indicate statistical difference (P,0.05).
doi:10.1371/journal.pone.0006679.t002
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The linear regression fit has been shown to provide a reasonably
close approximation to estimate the correlation of gene expression
with copy number and DNA methylation [33,34]. In these models
below, E, M and C represents GFP expression level, CMV
methylation level and GFP copy number, respectively, and bM and
bC represents the deterministic force of CMV methylation and
GFP copy number, respectively.
In analysis of transgenic fibroblast cells over a long time course in
culture, the model was: E=25.319M+0.065C+2.063 (r=0.984,
p,0.001) and bM=20.88, bC=0.124. We also analyzed the
correlation in different transgen i ct i s s u e s ,a n dt h em o d e lw a s :
E=20.74M+0.015C+0.667 (r=0.977, p,0.001) and
bM=20.517, bC=0.472. These results indicate that although both
copy number and promoter methylation can regulate transgene
expression levels in fibroblast cells and tissues, promoter methylation
appears to be more significant in affecting transgene expression
compared to copynumber. The modelin the passage ofthe transgenic
pig was: E=20.354M+0.069C20.319 (r=0.865, p=0.032) and
bM=20.102, bC=0.947, which suggests that copy number is
superior to promoter methylation in transgene expression regulation.
Discussion
To our knowledge, this is the first study to systematically analyze
the effect of copy number and promoter methylation on transgene
expression in domestic animals. Our results suggest that transgene
expression level is associated with copy number and CMV
promoter methylation status in transgenic pigs.
In random transfection, the transgene usually integrates into the
host genome in a tandem manner. High copy number tandem
integration is thought to lead to transgene silencing [17,35], however,
in the present study, the correlation of transgene expression level with
copy number was positive (bC.0). This difference may be caused by
a position effect, and further experiments are needed to clarify the
exact mechanism. CMV is very strong promoter in vitro [36]. Several
reports have described the CMV promoter as being silent in vivo,a n d
described a role of DNA methylation in silencing of the CMV
promoter [17,37–39]. A negative correlation between methylation of
the promoter and gene expression has been documented previously
[40,41], and was confirmed in our study (bM,0).
The decline of transgene expression with time may contribute to
the increase in promoter methylation rather than the loss of copy
Figure 4. Bisulfite sequence data for a representative region of CMV promoter. Native P is the native sequence of the CMV promoter. The
sequences from clones obtained after bisulfite treatment of DNA samples were aligned to the native sequence. For example, in control P cytosine
residues were not methylated and therefore converted to thymidine by the bisulfite treatment. CpG and non-CpG cytosines were highlighted on a
red and pink background, respectively.
doi:10.1371/journal.pone.0006679.g004
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level declines with time in vivo and in vitro [6,9]. This is similar with
the results observed here, and, in addition, both a loss of copy
number and increase in promoter methylation were observed. The
loss of a transgene integrated into the host genome has been
observed in K562 cells over a long time course in vitro [6].
However, we demonstrated the decline of transgene copy number
with aging in transgenic animals. The transgene copy number
decrease can be understood in two points below: firstly, it is
position dependent. A few reports described there were some sites
where transgene was inclined to integrate by random transfection,
such as LINE elements [6,27]. We believe the random transfection
may not result in random integration instead in some hot
integration sites and these hot integration sites may have the
common character easy for transgene to integrate, but, we propose
the hypothesis, it may be also easy for transgene to lose; secondly,
it is sequence dependent. The transgene we used is eGFP which is
heterogeneous from a kind of medusa, and we propose there may
be a sequence dependent mechanism to immune-mediated
destruction of transgene, as in the deletion of endogenous virus
[42,43]. An increase in transgene promoter methylation was
demonstrated during individual development of transgenic pigs
and transgenic fibroblast cells. This observation contradicts
previous conclusions that established methylation patterns can
be maintained and stably transmitted during mitosis [18,20]. A
gradual modification of methylation has been observed during
individual development of cloned pigs, and it is important to
correct the aberrant expression of imprinted genes in cloned
embryos and offspring [44,45]. The mechanism of increase in
transgene promoter methylation may be related to a defense
system targeted against the transgene [46,47]. In this case, it seems
that the decline of transgene expression may be caused by both the
loss of copy number and an increase in promoter methylation, but,
according to the b-value, the latter likely plays a more important
role.
The variegation of transgene expression in different tissues of
transgenic animals is more closely correlated with promoter
methylation than copy number. The CMV promoter exhibits
various expression profiles. Villuendas et al. (2001) [48] and Van
den Pol et al. (1998) [35] reported that the CMV promoter is
active in neurons, testis and certain other tissues of transgenic
mice, but Yang PH et al. (2008) [28] did not detect CMV activity
in heart, liver, spleen, lung, kidney, skin and muscle of transgenic
cattle. In our study, GFP expression was detected in all the tissues
examined, but the expression levels were different between tissues.
Varied transgene copies and promoter methylation were found in
tissues. A difference in DNA methylation among tissues is well
known, and the methylation status of an identical site in different
tissues may also be different [49]. Thus, the differential promoter
methylation status of the transgene among several tissues is
consistent to the previous observations. However, the mechanism
leading to the variegation of transgene copies is not clear.
Transgene in different tissues of transgenic animals generated by
pronuclear microinjection observed a mosaic pattern has been
reported [50,51]. But in the case of SCNT animals, all the
subsequent offspring and the cells within them originate from a
Figure 5. Methylation of CMV promoter. (A) Level of CMV methylation increased in founder transgenic pigs from newborn to maturity. The
increases in CMV methylation level from 26% to 40% (p=1.000) and from 19% to 38% (p=0.799) were observed in K25-2 and K25-3, respectively; (B)
Level of CMV methylation increased in transgenic fibroblast cells over time in culture. The increase in CMV methylation level from 20 to 90 days was
more than 3-fold from 26% to 81% (p=0.053); (C) Variegation of CMV methylation in various tissues of transgenic pig. Hypermethylation and
hypomethylation levels of CMV methylation were found in different tissues, but the difference was not significant (p=0.153); (D) Level of CMV
methylation in offspring transgenic pigs. The increase in CMV methylation level from 40% to 58% on average of offspring was detected (p=0.537).
Error bars denote standard deviations.
doi:10.1371/journal.pone.0006679.g005
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and its epigenetic status. Different cell division rates in different
tissues may lead to a difference in the extent of loss of transgene.
Nevertheless, according to the data reported here, different
transgene copy numbers and the promoter methylation status in
different tissues may be responsible for the expression varie-
gation.
The decline of transgene expression in offspring seems to result
in a loss of the transgene during passage. Founder transgenic pigs
mated with non-transgenic pigs may reduce the copy number,
consistent with previous works [27,52]. DNA methylation
associated with gene silencing is considered to be inherited during
mitosis, but cleared during meiosis, enabling the genome to return
to the totipotent state. Classic models of de novo methylation
describe erasure through two germlines, and then a resetting.
However, some reports have suggested that DNA methylation is
not completely erased, but inherited [53–55]. In this study, we
could not observe clearly the inheritance of the methylation status,
but an increase in promoter methylation level was obvious in the
offspring. Kearn M et al. (2000) [20] reported that a transgene
inherited from the mother is completely silenced in some offspring,
but, in all the genotype positive transgenic pigs we obtained, the
expression of the transgene transmitted by the mother was
detected. However, an obvious decline was observed, and,
according to multivariate linear regression analysis, the decline is
attributed to the loss of transgene copy number.
In the study, we found 1) decline of transgene copy number and
increase of promoter methylation level with time in vivo or in vitro,
and during passage, 2) the variegation pattern of transgene copy
number and promoter methylation status in various tissues, and 3)
all of these are associated with the changes of transgene expression.
It is known that the correlation of promoter methylation and copy
number with gene expression is not very tight, and position effect,
histone modifications or other epigenetic factors can also influence
transgene expression [20,23]. However, in conclusion, our results
at least demonstrate that transgene copy number and promoter
methylation are responsible for the regulation of transgene
expression in transgenic pigs.
Materials and Methods
Ethics statement
All the treatments of animals in this research followed by the
guideline of Northeast Agriculture University and were approved
by the committee. All animals (pigs) involved in this research were
raised and breed followed the guideline of Animal Husbandry
Department of Heilongjiang, P.R.China.
Establishment of GFP transgenic pigs and passage
Fibroblast cells derived from E32 fetuses were transfected by
liposome-mediated plasmid pEGFP-C1 (Clonech) containing
eGFP driven by the CMV promoter, which was based on a
random insertion of nonhomologous DNA vector into host
genome. After G418 selection, surviving cells were used as a
nuclear donor, and nuclear transfer was preformed as described
[29]. After sexual maturity, founder transgenic pigs were mated
with non-transgenic pigs to passage. Positive transgenic pigs were
identified by PCR using primers P1 and P2. The sequences of the
primers were 59-TGAACCGCATCGAGCTGAAGGG-39 (for-
ward) and 59-TCCAGCAGGACCATGTGATCGC-39 (reverse),
and PCR generated a 308-bp product. All DNA samples were
extracted using the Universal Genomic DNA Extraction Kit
Ver.3.0 (TaKaRa) according to the manufacturer’s instructions.
Southern blots
Each DNA sample was cleaved with EcoR I and Nhe
I(TaKaRa), which can digest the pig genome efficiently and form
a 800 bp fragment. The hybridization probe used to detect the
GFP transcription unit DNA (753 bp) was synthesized by PCR
using primers P3 and P5 and labeled by DIG Oligonucleotide 39-
End Labeling Kit (Roche). The sequences of the primers were 59-
GAGCAAGGGCGAGGAGCTGTTCA-39 (forward) and 59-
TGCAGAATTCGAAGCTTGAGC-39 (reverse).
Real-time PCR analysis
Real-time PCR procedure. Real-time PCR was performed
using SYBR Premix Ex Taq
TM (TaKaRa) and the 7300 Real-Time
PCR System (Applied Biosystems), with the following parameters:
95uC for 10 sec, followed by 40 two steps cycles at 95uC for 5 sec
and at 60uC for 31 sec. For RT-PCR, total RNAs were extracted
from each sample using the PureLink
TM Micro-to-Midi system
(Invitrogen) according to the manufacturer’s instructions, and
reverse transcription was to generate cDNAs using PrimeScript
TM
RT Reagent Kit (TaKaRa). Primers for the GFP gene were 59-
TGAACCGCATCGAGCTGAAGGG-39 (forward) and 59-ACC-
TTGATGCCGTTCTTCTGCTTG-39 (reverse). For absolute
quantitative PCR, the TFRC gene was used as a reference gene,
and the primers were 59-GAGACAGAAACTTTCGAAGC-39
(forward) and 59-GAAGTCTGTGGTATCCAATCC-39(reverse).
In relative quantitative RT-PCR, the b-actin gene was used as a
reference gene, and the primers were 59-AGATCGTGC-
GGGACATCAAG-39 (forward) and 59-GCGGCAGTGG-
CCATCTC-39 (reverse). The sizes of the amplification products
were110 bpforthe GFPgene,81 bpforthe TFRCgene and 93 bp
for the b-actin gene. For each DNA and cDNA sample, both target
and reference genes were always amplified independently on the
same plate and in the same experimental run in triplicate. The
meltingcurveanalysisshowed that all reactions were free ofprimer–
dimersorothernon-specificproducts(datanotshown). Ct valuewas
calculated by the Sequence Detection System software (Applied
Biosystems). In relative quantitative RT-PCR, the amount of target
normalized to reference was calculated by: 2
2DDCt.
Establishment of the absolute quantitative standard
curve
In order to examine the GFP copy number, generation of the
absolute quantitative standard curve was necessary. First, we
prepared a series of standard samples containing 1, 2, 4, 8, 16
copies of the GFP gene respectively, by mixing the wild type
genome of an E32 pig with plasmid pEGFP-C1. To make a
standard sample contain one copy of the GFP gene, the quality of
plasmid mixed with genomic DNA was:
a|b|0:5
3|109 ng (‘‘a’’
represents the size of plasmid). According to this principle, the
standard samples containing 1, 2, 4, 8, and 16 copies of the GFP
gene were prepared. The absolute quantitative standard curve was
drawn by plotting gCt (gCt=C tGFP 2 CtTFRC) against the log of
GFP gene copies of corresponding standard samples. The
parameters of the standard curve was: log2N=20.9354gCt
+3.4116 (R
2=0.9974, p,0.001).
Bisulfite sequencing
Bisulfite modification was performed on 0.3 ug of DNA from
each sample using the EZ DNA Methylation-Gold
TM Kit (Zymo
research), according to the instruction manual. PCR primers to
amplify the CMV were designed by MethPrimer software on line
(http://www.urogene.org/methprimer/), which was also used to
predict CpG islands and CpG sites in the sequence. The following
Transgene Expression in Pig
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region containing one CpG island with 14 CpG sites: gps:
59TGATTTTATGGGATTTTTTTATTTG39 (forward) and
gpa: 59ATTCACTAAACCAACTCTACTTATATAAAC39 (re-
verse). None of these bisulfite dependent residues lie within the first
6 bp of the 39 end of the primers, so if some of these were not
bisulfite converted this should have a limited effect upon primer
efficiency. The amplification of bisulfited-modified DNA was
performed using Hot start Taq
TM polymerase (TaKaRa), with the
following conditions: 94uC for 5 min, followed by 40 three steps
cycles at 94uC for 30 sec, 56uC for 30 sec and at 72uC for 1 min.
The PCR products were separated on 1% agarose gels and
purified, followed by sequencing (Invitrogen). The presence of a
cytosine residue after bisulfite treatment shows that the cytosine
residue was protected by methylation from bisulfite modification.
For each DNA sample, the number of cytosine residues that
remained as a cytosine was counted, and converted to a
percentage of the 14 CpG cytosines present in the 278-bp region
of the CMV that was analyzed. For the control, the pEGFP-C1
plasmid was treated and analyzed. At least five clones were
sequenced and analyzed for each sample.
Western blots
For Western blot analysis, total proteins were isolated from
different tissues of K25-3 and the ear of K25-2 and its offspring by
homogenization in lysis buffer (50 mM Tris-HCl, pH 7.5,
150 mM NaCl, 1% Triton X-100, 0.25% sodium deoxycholate,
and complete protease inhibitor cocktail (Roche)). The concen-
tration of proteins was measured by Bradford reagent (Sigma),
separated on 10% SDS-PAGE gels and transferred to Immobilon-
P membranes (Millipore). After blocking in 5% low-fat milk in
PBST (0.1% Tween 20 in PBS) for 1 h, the membranes were
incubated with GFP antibody (1:500, Santa Cruz Biotechnology)
or rabbit anti-Gapdh polyclonal antibody (1:2000, Santa Cruz
Biotechnology) overnight at 4uC. After washing in PBST, the
membranes were incubated in goat anti-rabbit antibody conju-
gated with horseradish peroxidase (1:5000) for 1 h, followed by
three washes in PBST. The signals were detected by ECL
Chemiluminescent kit (Amersham Pharmacia Biotech, Arlington
Heights).
Flow cytometry analysis
Fibroblast cells isolated from the ear of newborn K25-3 were
cultured and proliferated in DMEM+20% FBS (Gibco). The
fluorescence intensities of fibroblast cells over the time were
analyzed in a FACS Calibur (Becton-Dickinson). The argon laser
was tuned at 488 nm, and fluorescent cells were evaluated with a
525 nm band-pass filter. To set the parameters for flow cytometry
analysis, non-transfected fibroblast cells were used as a negative
control.
Statistical analysis
Statistical analysis was preformed using SPSS 13.0 for
MicroSoft
TM Windows. Data are shown as mean6SD. One-way
ANOVA was used to assess differences between groups. Duncan
method was employed for pairwise comparison and followed by
Bonferroni correction. Pearson correlation coefficient (PCC) and
multivariate linear regression analysis were performed to deter-
mine independent associations between GFP expression levels and
the variables of interest. P,0.05 (two-tailed) was considered
statistically significant.
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